MedTrace Logo

LACTACOL 01 - Impact of Breast Milk on the Neurodevelopment of Preterm Newborns

NCT01493063 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2023-05-10

No results posted yet for this study

Summary

The aim of the study is to estimate the impact of the protein content of breastmilk at the end of hospitalization of the preterm newborn, on the neurodevelopment at 2 years old.

The investigators expect a difference of at least 5 points of Development Quotient (DQ) when comparing extreme terciles of the protein content of breastmilk at the end of hospitalization.

Conditions

  • Prematurity of Fetus

Interventions

OTHER

Physiopathology

Samples of breastmilk and infant serum and questionnaires.

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Cécile Boscher, Doctor · Nantes University Hospital

Eligibility

Min Age
28 Weeks
Max Age
34 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-25
Primary Completion
2018-04-30
Completion
2025-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01493063 on ClinicalTrials.gov